| BRIACELL THERAPEUTICS NEW |
| Kanada |
| Gesundheit |
| CA1079303071 / A41DJH |
| 8BT (Frankfurt) / BCTX (NASDAQ) |
| FRA:8BT, ETR:8BT, 8BT:GR, NASDAQ:BCTX |
| - |
| https://briacell.com/ |
|
BriaCell Therapeutics Corp. is a clinical-stage bi..
>Volltext.. |
| 17.67 Mio. EUR |
| 8.39 Mio. EUR |
| - |
| -25.93 Mio. EUR |
| -24.59 Mio. EUR |
| -41.87 EUR |
| - |
| 2.33 Mio. EUR |
| -24.8 Mio. EUR |
| 3.07 |
| - |
| -77.18% |
| - |
| - |
| - |
| - |
| BRIACELL |
| 14.01.26 |
|